IMC LIVE is becoming virtual this year!

January 27th & 28th, 2021

For the past few months, we have been going through a global health crisis.

It is our duty as health professionals to ensure the safety of all.

The Organizing Committee is honored to announce the virtual 9th edition of IMC LIVE.

We intend to fulfill our scientific and teaching objectives this year, keeping our congress alive through a virtual platform and many digital surprises.

We look forward to seeing you online on January 27th and 28th, 2021!

Follow us on Social Media!


Pre-Course on Cardiac CT

Friday January, 13th 2017
Session facilitators:
Masaaki Okutsu, MD and Ahmed Zaatar, MD Toshiba

SESSION 1 – How useful is CT?
How to use CT in PCI: Basics / How to use CT in PCI: Plaque character estimation / Discussion on cases playback from IMCLIVE 4

SESSION 2 – How to use CT in CTO-PCI?
How to use CT in PCI: CT guided CTO-PCI / Discussion on cases preview from IMC LIVE 5

View program →

Only participants registered to IMC LIVE will be allowed to attend. 30 people maximum

This 5th Middle East Summit will focus on Chronic Total occlusions (CTO), with live cases broadcast!

The Scientific Committee is willing to welcome international and national operators and to exchange their clinical practice experience and encourage knowledge sharing.
This Summit is primarily based on live transmission cases, with interactive debates and dedicated lectures, during which experts from different countries will transmit their experience to the new interventional cardiologists’ generation.


This year, we have collaborated jointly with both Japanese CTO club and Euro CTO club – pioneers in CTOs – as well as many scientific societies from Middle East.


Experienced hands will be working in two different Cath labs, simultaneously live broadcast into the plenary room, performing selected CTO cases with different state-of-the-art techniques, tools and devices.
New updated multicenter trial results will be exposed and commented, to improve procedural success rate on patient outcomes. Consequently, as much more patients with complex lesions will be successfully treated, therefore we will face more demands to treat CTO.